OTC - ACTIVE INGREDIENT SECTION
Active Ingredient
Chlorhexidine Diacetate 1%
Active Ingredient
Chlorhexidine Diacetate 1%
Inactive Ingredients
Water, Cola Det SDC, Sodium Xylem Sulfate, Tocopheryl Acetate, Fragrance
Purpose
Antimicrobial
Uses
Prevent overgrowth of bacteria prior to surgical procedure
Prevent recurrent bacterial infections
Prevent infections around superficial wounds
Keep out of reach of children. If swallowed, get medical help
or contact a poison control center right away.
Warnings
For external use only.
Do not use:
If allergic to Chlorhexidine or other ingredients in formulation
In contact with the genital area
On wounds that exceed the superficial layer of skin.
When using this product
Avoid eye contact. Should contact occur,
rinse thoroughly with water.
Discontinue use and consult a health care practitioner
if irritation or allergic reaction develops.
Directions
Apply liberally to moistened area, wash and rinse thoroughly.
All product should be rinsed and dried immediately
| Class | Version | Type | Effective |
|---|---|---|---|
| CHLORHEXIDINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 362d7abb-94e6-4c60-9a58-266894157713 | Product name | 1 | 20231023 |
| 6c13b22c-b3ba-4127-b768-0132dd5ab0d1 | Product name | 1 | 20230829 |
| bb6d6c68-649d-4e6d-a1f6-603d969c8f68 | Product name | 1 | 20160303 |
| 424daadb-95de-8ece-97f5-235e3f7f0001 | Product name | 1 | 20140508 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 56149-002-02 | 2019-11-27 | C162847 | 48780-1 | 9855d018-d28c-cd31-e053-dbdaa90ab51a | Drug Facts |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 56149-002-02 | Serdaen | 3 g in 1 BOX | SOAP | 3 | 2 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| CHLORHEXIDINE ACETATE | ACTIVE INGREDIENT | 5908ZUF22Y | 2 | |
| CHLORHEXIDINE | ACTIVE MOIETY | R4KO0DY52L | 2 | |
| .ALPHA.-TOCOPHEROL ACETATE | INACTIVE INGREDIENT | 9E8X80D2L0 | 2 | |
| DIPROPYLENE GLYCOL | INACTIVE INGREDIENT | E107L85C40 | 2 | |
| MONOETHANOLAMINE | INACTIVE INGREDIENT | 5KV86114PT | 2 | |
| SODIUM SULFATE | INACTIVE INGREDIENT | 0YPR65R21J | 2 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 56149-002 | 56149-002-02 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CHLORHEXIDINE ACETATE | 5908ZUF22Y | ACTIB |
| WATER | 059QF0KO0R | IACT |
| SODIUM SULFATE | 0YPR65R21J | IACT |
| .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | IACT |
| DIPROPYLENE GLYCOL | E107L85C40 | IACT |
| MONOETHANOLAMINE | 5KV86114PT | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| SODIUM SULFATE | SODIUM SULFATE | 0YPR65R21J | SOAP / TOPICAL | 0.05 %w/w | ||
| .ALPHA.-TOCOPHEROL ACETATE | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | FILM / BUCCAL | 0.09 mg | ||
| SODIUM SULFATE | SODIUM SULFATE | 0YPR65R21J | TABLET, DELAYED RELEASE / ORAL | 16.24 mg | ||
| SODIUM SULFATE | SODIUM SULFATE | 0YPR65R21J | TABLET / ORAL | 182 mg | ||
| MONOETHANOLAMINE | 2-AMINOETHANOL | 5KV86114PT | TABLET, DELAYED RELEASE / ORAL | 1 mg | ||
| DIPROPYLENE GLYCOL | DIPROPYLENE GLYCOL | E107L85C40 | FILM, EXTENDED RELEASE / TRANSDERMAL | 296 mg | ||
| .ALPHA.-TOCOPHEROL ACETATE | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | TABLET / ORAL | 0.5 mg | ||
| DIPROPYLENE GLYCOL | DIPROPYLENE GLYCOL | E107L85C40 | SYSTEM / TRANSDERMAL | 6 mg | ||
| SODIUM SULFATE | SODIUM SULFATE | 0YPR65R21J | SHAMPOO / TOPICAL | 5 %w/w | ||
| SODIUM SULFATE | SODIUM SULFATE | 0YPR65R21J | TABLET, COATED / ORAL | NA | ||
| DIPROPYLENE GLYCOL | DIPROPYLENE GLYCOL | E107L85C40 | FILM, EXTENDED RELEASE / BUCCAL | 30 mg | ||
| .ALPHA.-TOCOPHEROL ACETATE | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | CAPSULE / ORAL | 2 mg | ||
| SODIUM SULFATE | SODIUM SULFATE | 0YPR65R21J | SOLUTION/ DROPS / OPHTHALMIC | 13 mg | ||
| SODIUM SULFATE | SODIUM SULFATE | 0YPR65R21J | SOLUTION / OPHTHALMIC | 0.14 %w/v |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| cb80b579-2303-4261-8eba-426e54b7ffc7 | e34e6caa-3360-4549-8a84-d8adcab1b3bb | 2013-06-13 | Warnings | cb80b579-2303-4261-8eba-426e54b7ffc7 e34e6caa-3360-4549-8a84-d8adcab1b3bb |
Adverse event summaries are temporarily unavailable. Other product information remains available.